Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas

BACKGROUND: Surgery, adjuvant chemotherapy, and radiotherapy are the primary treatment options for soft tissue sarcomas (STSs). However, identifying ways to improve the prognosis of patients with STS remains a considerable challenge. Evidence shows that the dysregulation of alternative splicing (AS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xia, Huang, Wen-ting, He, Rong-quan, Ma, Jie, Lin, Peng, Xie, Zu-cheng, Ma, Fu-chao, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708253/
https://www.ncbi.nlm.nih.gov/pubmed/31443718
http://dx.doi.org/10.1186/s12967-019-2029-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708253/
https://www.ncbi.nlm.nih.gov/pubmed/31443718
http://dx.doi.org/10.1186/s12967-019-2029-6

Ejemplares similares